Related Experiment Video

Updated: Jun 1, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report

T Pressler1, C Bohmova, S Conway

  • 1Copenhagen University Hospital, Cystic Fibrosis Center, Copenhagen, Denmark. tanja.pressler@rh.regionh.dk

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|June 11, 2011
PubMed

Insights

Chronic Pseudomonas aeruginosa infection is a major cause of death in cystic fibrosis (CF) patients. New classification systems are needed to improve clinical trials for this persistent pulmonary pathogen.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Genetics

Background:

  • Pseudomonas aeruginosa (P. aeruginosa) chronic pulmonary infection affects 80% of adult cystic fibrosis (CF) patients.
  • Chronic P. aeruginosa infection is the leading cause of mortality and morbidity in CF.
  • The progression from intermittent to chronic infection involves mucoid variants and rising anti-Pseudomonas antibodies.

Framework:

  • A validated, universally accepted classification system for P. aeruginosa infection in CF is currently lacking.
  • Such a classification is crucial for patient selection in clinical trials.
  • It is also needed as a reliable study endpoint for therapeutic interventions.

Implementation:

  • Optimizing current therapeutic strategies is essential.
  • Identifying and developing novel anti-Pseudomonas agents is a priority.
  • Clinical trials in CF patients are complex due to disease heterogeneity.

Implications:

  • Improved patient stratification will enhance the efficacy of clinical trials.
  • A standardized classification will facilitate the development of new treatments for chronic P. aeruginosa infections.
  • Addressing this challenge is vital for improving outcomes in cystic fibrosis.

More Related Videos

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection06:56

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Published on: February 20, 2020

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae06:04

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae

Published on: June 13, 2025

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...